Display options
Share it on

JIMD Rep. 2017;33:55-60. doi: 10.1007/8904_2016_580. Epub 2016 Aug 19.

Novel Homozygous Missense Mutation in SPG20 Gene Results in Troyer Syndrome Associated with Mitochondrial Cytochrome c Oxidase Deficiency.

JIMD reports

Ronen Spiegel, Devorah Soiferman, Avraham Shaag, Stavit Shalev, Orly Elpeleg, Ann Saada

Affiliations

  1. Department of Pediatrics B, Emek Medical Center, Afula, 1834111, Israel. [email protected].
  2. Genetic Institute, Emek Medical Center, Afula, Israel. [email protected].
  3. Rappaport School of Medicine, Technion, Haifa, Israel. [email protected].
  4. Monique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  5. Department of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  6. Genetic Institute, Emek Medical Center, Afula, Israel.
  7. Rappaport School of Medicine, Technion, Haifa, Israel.

PMID: 27539578 PMCID: PMC5413448 DOI: 10.1007/8904_2016_580

Abstract

Troyer syndrome is an autosomal recessive form of hereditary spastic paraplegia (HSP) caused by deleterious mutations in the SPG20 gene. Although the disease is associated with a loss of function mechanism of spartin, the protein encoded by SPG20, the precise pathogenesis is yet to be elucidated. Recent data indicated an important role for spartin in both mitochondrial maintenance and function. Here we report a child presenting with progressive spastic paraparesis, generalized muscle weakness, dysarthria, impaired growth, and severe isolated decrease in muscle cytochrome c oxidase (COX) activity. Whole exome sequencing identified the homozygous c.988A>G variant in SPG20 gene (p.Met330Val) resulting in almost complete loss of spartin in skeletal muscle. Further analyses demonstrated significant tissue specific reduction of COX 4, a nuclear encoded subunit of COX, in muscle suggesting a role for spartin in proper mitochondrial respiratory chain function mediated by COX activity. Our findings need to be verified in other Troyer syndrome patients in order to classify it as a form of HSP caused by mitochondrial dysfunction.

Keywords: Cytochrome c oxidase; Hereditary spastic paraplegia; Mitochondria; Oxidative phosphorylation; SPG20; Troyer syndrome

References

  1. J Cell Biol. 2009 Mar 23;184(6):881-94 - PubMed
  2. Mol Biol Cell. 2007 May;18(5):1683-92 - PubMed
  3. J Cell Biol. 2003 Nov 24;163(4):777-87 - PubMed
  4. Biochem J. 2005 Dec 15;392(Pt 3):625-32 - PubMed
  5. Nat Genet. 2002 Aug;31(4):347-8 - PubMed
  6. J Neurol. 2015 Jul;262(7):1601-12 - PubMed
  7. J Neurochem. 2006 Sep;98(6):1908-19 - PubMed
  8. Neurology. 2015 Feb 17;84(7):659-67 - PubMed
  9. Arch Neurol. 2008 Apr;65(4):520-4 - PubMed
  10. J Biol Chem. 2008 Jun 6;283(23):15694-700 - PubMed
  11. Ann Neurol. 2010 Apr;67(4):516-25 - PubMed
  12. Mol Cell. 2015 Oct 1;60(1):47-62 - PubMed
  13. Am J Med Genet A. 2016 Jul;170(7):1780-5 - PubMed
  14. Hum Mutat. 2016 Feb;37(2):165-9 - PubMed
  15. Mol Cell Probes. 2015 Oct;29(5):315-8 - PubMed
  16. Anal Biochem. 2004 Dec 1;335(1):66-72 - PubMed
  17. PLoS One. 2015 Jun 26;10(6):e0130455 - PubMed
  18. J Med Genet. 2012 Dec;49(12):777-84 - PubMed
  19. PLoS One. 2011 Apr 29;6(4):e19290 - PubMed
  20. Cell Rep. 2015 Jan 13;10(2):148-61 - PubMed
  21. Lancet Neurol. 2011 Sep;10(9):806-18 - PubMed

Publication Types